AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Tempest Therapeutics, Inc. Director's Dealing 2016

Sep 13, 2016

34632_dirs_2016-09-12_3597884a-94d8-4591-ab3d-a989f4af3913.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2016-09-06

Reporting Person: Couturier Christophe (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	600	Direct